cvn424
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Aug 31, 2018 (NCT03657030)
Timeline
Indications
Mechanism of action
- G-protein coupled receptor 6INHIBITOR
GPR6 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06553027 | Phase 3 | Sep 20, 2024 | Cerevance |
| NCT06006247 | Phase 2 | Sep 11, 2023 | Cerevance |
| NCT05635461 | Phase 1 | Oct 9, 2022 | Cerevance |
| NCT04191577 | Phase 2 | Dec 2, 2019 | Cerevance |
| NCT03657030 | Phase 1 | Aug 31, 2018 | Cerevance |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cerevance | For profit | 5 | 5 | 3 | 2018 |
1 organizations
Page 1 / 1